Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Stanford Healthcare – Spinal Muscular Atrophy
213 Quarry RoadPalo Alto, California, United States
Phone Web
Stanford Neuromuscular Program has extensive experience in diagnosing and treating spinal muscular atrophy (SMA). We are at the forefront of developing and validating new treatment approaches, such as Spinraza, the only treatment available for spinal muscular atrophy.
This disease-modifying drug halts the progression of spinal muscular atrophy and may help people regain some of the motor function they have lost. Our research team treated the first infant ever to receive Spinraza in 2013. After the FDA approved Spinraza in 2016, we treated the very first adult living with spinal muscular atrophy.
We offer specialized, comprehensive care for those living with spinal muscular atrophy at our multidisciplinary Neuromuscular Clinic Program.
Related Content
-
Genetic Architecture of Motor Neuron DiseasesMotor neuron diseases (MNDs) are rare an...
-
Magnetic Resonance Reveals Mitochondrial Dysfunction and Muscle Remodelling in Spinal Muscular AtrophyGenetic therapy has changed the prognosi...
-
UW Health – Spinal Muscular AtrophyOur UW Health Kids experts are national ...
-
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult With 5q-Related Spinal Muscular Atro...Spinal muscular atrophy (SMA) is a hered...
-
Newborn Screening, Treatment Make Big Difference With Rare Muscle DisorderMateo Medina has never walked or talked....
-
Comparison of Nusinersen and Evrysdi in the Treatment of Spinal Muscular AtrophySpinal Muscular Atrophy (SMA) is a genet...
-
Assessment of Cerebral Spinal Fluid Biomarkers and microRNA-Mediated Disease Mechanisms in Spinal Muscular Atrophy P...Cerebral spinal fluid (CSF) is a promisi...